Rainbow Children's [RAINBOW] vs Alivus Life Sciences [GLS] Detailed Stock Comparison

Rainbow Children's

NSE
Loading...

Alivus Life Sciences

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Rainbow Children's wins in 4 metrics, Alivus Life Sciences wins in 14 metrics, with 0 ties. Alivus Life Sciences appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricRainbow Children'sAlivus Life SciencesBetter
P/E Ratio (TTM)53.7631.45Alivus Life Sciences
Price-to-Book Ratio9.374.50Alivus Life Sciences
Debt-to-Equity Ratio51.770.01Alivus Life Sciences
PEG Ratio1.522.05Rainbow Children's
EV/EBITDA30.6416.21Alivus Life Sciences
Profit Margin (TTM)16.73%53.28%Alivus Life Sciences
Operating Margin (TTM)19.67%28.97%Alivus Life Sciences
EBITDA Margin (TTM)19.67%28.97%Alivus Life Sciences
Return on Equity16.50%20.19%Alivus Life Sciences
Return on Assets (TTM)10.24%16.52%Alivus Life Sciences
Free Cash Flow (TTM)$2.50B$2.85BAlivus Life Sciences
Dividend Yield0.40%N/AN/A
1-Year Return-5.84%-20.70%Rainbow Children's
Price-to-Sales Ratio (TTM)8.945.23Alivus Life Sciences
Enterprise Value$138.29B$111.35BRainbow Children's
EV/Revenue Ratio8.995.10Alivus Life Sciences
Gross Profit Margin (TTM)86.54%55.55%Rainbow Children's
Revenue per Share (TTM)$152$178Alivus Life Sciences
Earnings per Share (Diluted)$25.19$38.38Alivus Life Sciences
Beta (Stock Volatility)0.19N/AN/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Rainbow Children's vs Alivus Life Sciences Stock Performance Analysis

Loading Price Chart...

Rainbow Children's
Alivus Life Sciences
Rainbow Children's Stock Overview | Alivus Life Sciences Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Rainbow Children's-1.87%-0.87%-10.30%-15.52%-5.46%-14.52%
Alivus Life Sciences0.21%-1.92%1.46%-8.52%-4.02%-8.27%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Rainbow Children's-5.84%101.27%204.41%204.41%204.41%204.41%
Alivus Life Sciences-20.70%130.14%24.82%24.82%24.82%24.82%

News Based Sentiment: Rainbow Children's vs Alivus Life Sciences

Rainbow Children's

News based Sentiment: POSITIVE

The month of October saw a positive catalyst with Axis Securities initiating a 'Buy' rating and a 20% price target increase, alongside continued strong financial performance and a history of impressive returns since its IPO. These factors collectively strengthen the investment case for Rainbow Children's Medicare.

View Rainbow Children's News Sentiment Analysis

Alivus Life Sciences

News based Sentiment: NEUTRAL

October's developments for Alivus Life Sciences show a mix of steady financial performance with modest growth in Q1FY26, a long-term strategic outlook, and some bearish technical indicators. The increased analyst coverage and institutional activity suggest growing market attention, but the overall picture is one of cautious optimism rather than dramatic change.

View Alivus Life Sciences News Sentiment Analysis

Performance & Financial Health Analysis: Rainbow Children's vs Alivus Life Sciences

MetricRAINBOWGLS
Market Information
Market Cap i₹135.08B₹114.20B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i135,326473,217
90 Day Avg. Volume i122,745201,188
Last Close₹1,328.90₹934.00
52 Week Range₹1,218.00 - ₹1,709.60₹850.00 - ₹1,251.00
% from 52W High-22.27%-25.34%
All-Time High₹1,709.60 (Nov 25, 2024)₹1,335.10 (Sep 16, 2024)
% from All-Time High-22.27%-30.04%
Growth Metrics
Quarterly Revenue Growth0.07%0.27%
Quarterly Earnings Growth0.35%0.12%
Financial Health
Profit Margin (TTM) i0.17%0.53%
Operating Margin (TTM) i0.20%0.29%
Return on Equity (TTM) i0.17%0.20%
Debt to Equity (MRQ) i51.770.01
Cash & Liquidity
Book Value per Share (MRQ)₹144.58₹207.22
Cash per Share (MRQ)₹68.30N/A
Operating Cash Flow (TTM) i₹3.63B₹4.70B
Levered Free Cash Flow (TTM) i₹2.43B₹4.71B
Dividends
Last 12-Month Dividend Yield i0.40%N/A
Last 12-Month Dividend i₹6.00₹0.00

Valuation & Enterprise Metrics Analysis: Rainbow Children's vs Alivus Life Sciences

MetricRAINBOWGLS
Price Ratios
P/E Ratio (TTM) i53.7631.45
Forward P/E i42.9622.31
PEG Ratio i1.522.05
Price to Sales (TTM) i8.945.23
Price to Book (MRQ) i9.374.50
Market Capitalization
Market Capitalization i₹135.08B₹114.20B
Enterprise Value i₹138.29B₹111.35B
Enterprise Value Metrics
Enterprise to Revenue i8.995.10
Enterprise to EBITDA i30.6416.21
Risk & Other Metrics
Beta i0.19N/A
Book Value per Share (MRQ) i₹144.58₹207.22

Financial Statements Comparison: Rainbow Children's vs Alivus Life Sciences

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)RAINBOWGLS
Revenue/Sales i₹3.53B₹6.42B
Cost of Goods Sold i₹474.98M₹2.85B
Gross Profit i₹3.05B₹3.57B
Research & Development iN/AN/A
Operating Income (EBIT) i₹694.36M₹1.75B
EBITDA i₹1.24B₹2.01B
Pre-Tax Income i₹713.74M₹1.85B
Income Tax i₹175.69M₹481.87M
Net Income (Profit) i₹538.05M₹1.37B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)RAINBOWGLS
Cash & Equivalents i₹202.55M₹4.46B
Total Current Assets i₹8.22B₹20.96B
Total Current Liabilities i₹1.51B₹4.64B
Long-Term Debt i₹7.42B₹133.80M
Total Shareholders Equity i₹14.75B₹25.38B
Retained Earnings i₹9.57BN/A
Property, Plant & Equipment i₹2.55B₹8.04B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)RAINBOWGLS
Operating Cash Flow i₹241.81MN/A
Capital Expenditures i₹-250.87MN/A
Free Cash Flow i₹48.93MN/A
Debt Repayment i₹380,000N/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricRAINBOWGLS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i135,326473,217
Average Daily Volume (90 Day) i122,745201,188
Shares Outstanding i101.55M122.53M
Float Shares i48.16MN/A
% Held by Insiders i0.54%N/A
% Held by Institutions i0.31%N/A

Dividend Analysis & Yield Comparison: Rainbow Children's vs Alivus Life Sciences

MetricRAINBOWGLS
Last 12-Month Dividend i₹6.00₹0.00
Last 12-Month Dividend Yield i0.40%N/A
3-Year Avg Annual Dividend i₹3.67₹18.00
3-Year Avg Dividend Yield i0.28%3.82%
3-Year Total Dividends i₹11.00₹54.00
Ex-Dividend DateJun 27, 2025Oct 17, 2023